Emergent Capital Inc  

(Public, NYSE:EMG)   Watch this stock  
Find more results for NYSE:IFT
3.57
-0.04 (-1.11%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 3.50 - 3.63
52 week 3.10 - 5.87
Open 3.52
Vol / Avg. 175,874.00/71,758.00
Mkt cap 98.11M
P/E     -
Div/yield     -
EPS -1.60
Shares 27.79M
Beta 1.08
Inst. own 72%
Nov 7, 2016
Q3 2016 Emergent Capital Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 3, 2016
Q2 2016 Emergent Capital Inc Earnings Call
Aug 3, 2016
Q2 2016 Emergent Capital Inc Earnings Release
Jun 2, 2016
Emergent Capital Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin - -64.79%
Operating margin - -83.38%
EBITD margin - -64.41%
Return on average assets -7.31% -6.28%
Return on average equity -18.85% -13.95%
Employees 32 -
CDP Score - -

Address

5355 Town Center Rd Ste 701
BOCA RATON, FL 33486-1081
United States - Map
+1-561-9954200 (Phone)
+1-561-9954201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Emergent Capital, Inc., formerly Imperial Holdings, Inc., is a specialty finance company that invests in asset classes, primarily life settlements. The Company, through its subsidiary companies, owns a portfolio of approximately 630 life insurance policies (life settlements). The Company purchases individual policies and portfolios of life insurance policies and manages those assets based on actuarial and market data. The Company provides customized liquidity solutions to owners of illiquid financial assets in two markets, which include life finance and structured settlements. The Company focuses on lending to outright purchases of portfolios, to tertiary trades, as well as individual secondary market purchases. The Company invests in short and long-term life settlement investments.

Officers and directors

Phillip F. Goldstein Independent Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Antony Mitchell Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Miriam Martinez Acting Chief Financial Officer
Age: 59
Bio & Compensation  - Reuters
David Sasso Senior Vice President - Corporate Development & Investor Relations
Bio & Compensation  - Reuters
Christopher O'Reilly General Counsel, Secretary
Bio & Compensation  - Reuters
James M. Chadwick Director
Bio & Compensation  - Reuters
Richard Dayan Director
Age: 72
Bio & Compensation  - Reuters
Gilbert E Nathan Director
Bio & Compensation  - Reuters
Michael A. Crow Independent Director
Age: 52
Bio & Compensation  - Reuters
Andrew Dakos Independent Director
Age: 49
Bio & Compensation  - Reuters